Search

everythinglearnresearchcommunity

for

Search:↓

In 2024, the FDA approved 27 innovative small-molecule drugs, with many offering significant treatment improvements.

The study was retracted.

People with hypohidrotic ectodermal dysplasia are more likely to experience long-term fatigue and hair loss after COVID-19.

BMI is a simple, cost-effective tool for screening obesity and related diseases.

Rare ULBP3 gene changes may raise the risk of Alopecia areata, a certain FAS gene deletion could cause a dysfunctional protein in an immune disorder, and having one copy of a specific genetic deletion is okay, but two copies cause sickle cell disease.

Lifestyle changes and environmental strategies can help address declining testosterone levels.

Patients treated in Respiratory Intensive Care Units for COVID-19 are more likely to get mood disorders than those in other care settings.

A woman with childhood growth hormone deficiency had multiple hormone deficiencies and developed serious lung and kidney problems later in life.

A 68-year-old woman with lupus and blood disorders improved after increased steroids and immunoglobulin treatment.

Organoids help study and treat genetic diseases, offering personalized medicine and therapy testing.

Frontal fibrosing alopecia can be managed with personalized combination therapies, but no cure exists yet.

Hair follicle sampling is a feasible method to measure FMRP and FMR1 mRNA levels in children.

Stromal Vascular Fraction might help with male sexual dysfunction, but more research is needed to confirm its safety and effectiveness.

Fetuin A may increase collagen production and promote scarring.

Frontal fibrosing alopecia shows increased inflammation and JAK-STAT pathway activity without reduced hair proteins.

A new device, IVL-PPF Microsphere®, was created to deliver a hair loss drug for up to 3 months with one injection, potentially replacing daily pills.

Some treatments like intralesional steroids and 5α-reductase inhibitors are effective for frontal fibrosing alopecia, but more research is needed.

Critically ill patients may experience temporary hair loss after a fever.

5-alpha-reductase inhibitors may help stabilize or slow down hair loss in some frontal fibrosing alopecia patients, but more research is needed to confirm their effectiveness and safety.

Most men with Frontal fibrosing alopecia also lose facial hair and the condition may be linked to hormone levels and sunscreen use.

Frontal Fibrosing Alopecia is a hair loss condition mainly affecting postmenopausal women, with unclear causes and various clinical patterns.

Frontal Fibrosing Alopecia might be an autoimmune disease.

Sprouty and FGF balance is crucial for normal feather shape and size.

Special immune cells called Tregs can help prevent lung scarring by blocking a specific growth factor.

Cepharanthine dry powder inhalers may effectively treat acute lung injury by reducing inflammation.

Finasteride may help treat frontal fibrosing alopecia, but more research is needed.

The model improves understanding of androgen interactions by focusing on signal intensity and system capacity.

Selenium therapy improved health in cystic fibrosis patients with fewer side effects at a lower dose.

Multiple eye conditions were studied, highlighting the importance of various imaging methods for diagnosis, the vision side effects of drugs tamoxifen and Propecia, and the usefulness of optical coherence tomography for diagnosing and monitoring macular and retinal diseases.

A rare skin condition causes red, dark, bumpy facial lesions.